Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer

T cells recognize cancer cells via human leukocyte antigen (HLA)/peptide complexes and, when disease overtakes these immune mechanisms, immunotherapy can exogenously target these same HLA/peptide surface markers. We previously identified an HLA-A2-presented peptide derived from macrophage migration...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Patterson, Andrea M, Kaabinejadian, Saghar, McMurtrey, Curtis P, Bardet, Wilfried, Jackson, Ken W, Zuna, Rosemary E, Husain, Sanam, Adams, Gregory P, MacDonald, Glen, Dillon, Rachelle L., Ames, Harold, Buchli, Rico, Hawkins, Oriana E, Weidanz, Jon A, Hildebrand, William H
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747837/
https://ncbi.nlm.nih.gov/pubmed/26719579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0658
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados